ARGA Investment Management LP Invests $950,000 in Envista Holdings Corporation $NVST

ARGA Investment Management LP bought a new position in Envista Holdings Corporation (NYSE:NVST) during the third quarter, Holdings Channel.com reports. The fund bought 46,644 shares of the company’s stock, valued at approximately $950,000.

A number of other large investors have also recently added to or reduced their stakes in NVST. GAMMA Investing LLC grew its position in Envista by 34.3% in the third quarter. GAMMA Investing LLC now owns 2,498 shares of the company’s stock worth $51,000 after buying an additional 638 shares during the last quarter. Claret Asset Management Corp boosted its stake in shares of Envista by 6.5% during the 2nd quarter. Claret Asset Management Corp now owns 11,827 shares of the company’s stock worth $231,000 after acquiring an additional 724 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after acquiring an additional 949 shares during the last quarter. Farther Finance Advisors LLC raised its position in shares of Envista by 317.6% during the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after purchasing an additional 1,026 shares during the period. Finally, Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Envista by 5.6% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 20,100 shares of the company’s stock valued at $393,000 after purchasing an additional 1,067 shares during the last quarter.

Envista Stock Performance

Shares of NVST opened at $23.86 on Friday. The company has a market capitalization of $3.92 billion, a PE ratio of 265.10, a PEG ratio of 1.09 and a beta of 0.99. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.02 and a current ratio of 2.37. The company’s 50 day moving average price is $21.95 and its 200 day moving average price is $20.93. Envista Holdings Corporation has a 52 week low of $14.22 and a 52 week high of $25.41.

Envista (NYSE:NVST) last issued its earnings results on Wednesday, October 29th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Envista had a net margin of 0.58% and a return on equity of 5.90%. The company had revenue of $669.90 million during the quarter, compared to analyst estimates of $639.49 million. During the same quarter last year, the business posted $0.12 EPS. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. Research analysts expect that Envista Holdings Corporation will post 1 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the company. Stifel Nicolaus set a $25.00 price target on Envista in a research note on Thursday, October 30th. Evercore ISI reissued an “outperform” rating on shares of Envista in a research report on Friday, October 31st. Robert W. Baird set a $27.00 price target on shares of Envista in a research report on Friday, October 31st. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Envista in a research note on Monday, December 29th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Envista from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Tuesday, December 16th. Five analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $22.17.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.